HSP90-targeted inflammation and infection imaging and therapy
US-11065350-B2 · Jul 20, 2021 · US
Positron imaging tomography imaging agent composition and method for bacterial infection
US11857352B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11857352-B2 |
| Application number | US-201716330679-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 6, 2017 |
| Priority date | Sep 6, 2016 |
| Publication date | Jan 2, 2024 |
| Grant date | Jan 2, 2024 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a composition comprising the compound having the structure: or a salt of the compound; 4-amino-2-[ 19 F]-fluorobenzoic acid or a salt of 4-amino-2-[ 19 F]-fluorobenzoic acid; and at least one acceptable carrier.
First claim
Opening claim text (preview).
What is claimed is: 1. A composition comprising the compound having the structure: or a salt of the compound; 4-amino-2-[ 19 F]-fluorobenzoic acid or a salt of 4-amino-2-[ 19 F]-fluorobenzoic acid; and at least one acceptable carrier, wherein the ratio of the 4-amino-2-[ 18 F]-flurobenzoic acid to the 4-amino-2-[ 19 F]-flurobenzoic acid is in the range from 1:90 to 1:550. 2. The composition of claim 1 , wherein the ratio of the 4-amino-2-[ 18 F]-fluorobenzoic acid to the 4-amino-2-[ 19 F]-fluorobenzoic acid is in a range from 1:324 to 1:500. 3. The composition of claim 1 , wherein the ratio of the 4-amino-2-[ 18 F]-fluorobenzoic acid to the 4-amino-2-[ 19 F]-fluorobenzoic acid is in a range from 1:99 to 1:324. 4. The composition of claim 1 , wherein the radiochemical purity of 4-amino-2-[ 18 F]-fluorobenzoic acid is at least 95%. 5. The composition of claim 1 , wherein the ratio of the 4-amino-2-[ 18 F]-fluorobenzoic acid to the 4-amino-2-[ 19 F]-fluorobenzoic acid is in a range from 1:99 to 1:500.
Assignees
Inventors
Classifications
- A61B6/037Primary
Emission tomography · CPC title
carboxylic acid carriers, fatty acids (amino acids A61K51/0406) · CPC title
Antibacterial agents · CPC title
- C07B59/001Primary
Acyclic or carbocyclic compounds · CPC title
Formation of amino and carboxyl groups · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11857352B2 cover?
- The present invention provides a composition comprising the compound having the structure: or a salt of the compound; 4-amino-2-[ 19 F]-fluorobenzoic acid or a salt of 4-amino-2-[ 19 F]-fluorobenzoic acid; and at least one acceptable carrier.
- Who is the assignee on this patent?
- Univ New York State Res Found
- What technology area does this patent fall under?
- Primary CPC classification A61B6/037. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).